Application
Antibody used in IHC on Human Liver.Application
Antibody used in WB on Human HeLa cells at 1 ug/ml (Lane A: Primary Antibody and Lane B: Primary Antibody + Blocking Peptide ).Application
Antibody used in WB on Human HeLa at 1 ug/ml.Application
Antibody used in IHC on Human Liver.WB
mRNA expression of FATP2 (a) and FABP1 (b) in livers of female and male mice; protein expression of FATP2 (c) and FABP1 (d) in livers of female mice.| Product Name | SLC27A2 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | SLC27A2 is an isozyme of long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme activates long-chain, branched-chain and very-long-chain fatty acids containing 22 or more carbons to their CoA derivatives. It is expressed primarily in liver and kidney, and is present in both endoplasmic reticulum and peroxisomes, but not in mitochondria. Its decreased peroxisomal enzyme activity is in part responsible for the biochemical pathology in X-linked adrenoleukodystrophy.The protein encoded by this gene is an isozyme of long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme activates long-chain, branched-chain and very-long-chain fatty acids containing 22 or more carbons to their CoA derivatives. It is expressed primarily in liver and kidney, and is present in both endoplasmic reticulum and peroxisomes but not in mitochondria. Its decreased peroxisomal enzyme activity is in part responsible for the biochemical pathology in X-linked adrenoleukodystrophy.1) Mihalik, S.J., (2002) J. Biol. Chem. 277 (27), 24771-24779. |
| Immunogen | Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human SLC27A2. |
| Modification | Acetylated |
| Clonality | Polyclonal |
|---|---|
| Isotype | Cocktail |
| Host Species | Rabbit |
| Tested Applications | ELISAIHCWB |
| WB:1:500~1:2000 IHC:1:50~1:200 |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | SLC27A2 |
|---|---|
| Alternative Names | SLC27A2 ACSVL1 FACVL1 FATP2 HsT17226 VLACS VLCS hFACVL1 |
| Molecular Weight(MW) | 70 kDa |
Application
Antibody used in IHC on Human Liver.
Application
Antibody used in WB on Human HeLa cells at 1 ug/ml (Lane A: Primary Antibody and Lane B: Primary Antibody + Blocking Peptide ).
Application
Antibody used in WB on Human HeLa at 1 ug/ml.
Application
Antibody used in IHC on Human Liver.
WB
mRNA expression of FATP2 (a) and FABP1 (b) in livers of female and male mice; protein expression of FATP2 (c) and FABP1 (d) in livers of female mice.| Positive Control | HeLa Cell Lysate |
|---|---|
| Application Notes | WB:1:500~1:2000 IHC:1:50~1:200 |
| Form | Liquid |
|---|---|
| Storage Instructions | For short periods of storage (days) store at 4˚C. For longer periods of storage, store SLC27A2 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles. |
| Storage Buffer | Antibody is lyophilized in PBS buffer with 2% sucrose. Add 50 μL of distilled water. Final antibody concentration is 1 mg/mL. |
